Tablet: Gastroesophageal Reflux Disease (GERD): Treatment of erosive reflux esophagitis; long-term management of patients with healed esophagitis to prevent relapse; symptomatic treatment of GERD.
In Combination with Appropriate Antibacterial Therapeutic Regimens: Eradication of Helicobacter pylori; healing of H. pylori-associated duodenal ulcer; and prevention of relapse of peptic ulcers in patients with H. pylori-associated ulcers.
Patients Requiring Continued NSAID Therapy: Healing of gastric ulcers associated with NSAID therapy; prevention of gastric and duodenal ulcers associated with NSAID therapy in patients at risk.
Prolonged treatment after IV-induced prevention of rebleeding of peptic ulcers.
Treatment of Zollinger Ellison syndrome.
Granules: Nexium oral suspension is primarily indicated for treatment of GERD in children 1-11 years old.
Gastroesophageal Reflux Disease (GERD): Treatment of endoscopically proven erosive reflux esophagitis; symptomatic treatment of GERD.
Nexium oral suspension may also be used by patients having difficulty in swallowing dispersed Nexium gastro-resistant tablets. For indications in patients ≥12 years, reference is made to the Nexium gastro-resistant tablet prescribing information.